Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare LlcfiledCriticalBayer Healthcare Llc
Publication of DOP2015000049ApublicationCriticalpatent/DOP2015000049A/en
La presente invención se refiere a una composición farmacéutica recubierta que contiene regorafenib, un hidrato, solvato, metabolito o sal farmacéuticamente aceptable del mismo, o un polimorfo del mismo y su procedimiento de preparación y su uso para tratar trastornos.The present invention relates to a coated pharmaceutical composition containing regorafenib, a hydrate, solvate, metabolite or pharmaceutically acceptable salt thereof, or a polymorph thereof and its preparation process and its use for treating disorders.
Azaindole-derived compounds, pi3k inhibitors; Preparation method; pharmaceutical composition; pharmaceutical combination; and its use for the treatment of immunological disorders, cancer and cardiovascular diseases.